Georges Gemayel - Jan 3, 2022 Form 4 Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Role
Executive Chair of the Board, Director
Signature
/s/ Brian Piekos, attorney-in-fact
Stock symbol
IRON
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 03:04 PM
Previous filing
Nov 16, 2021
Next filing
Feb 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRON Stock Option (Right to Buy) Award $0 +793K $0.00 793K Jan 3, 2022 Common Stock 793K $3.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the Option Shares shall become exercisable on August 5, 2022 and the remaining 50% of the Option Shares shall become exercisable on August 5, 2023.